No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MCRB240517P1500
- 0.85
- +0.40+88.89%
15min DelayClose May 9 16:00 ET
0.85High0.85Low
0.85Open0.45Pre Close1 Volume7 Open Interest1.50Strike Price85.00Turnover380.41%IV-10.19%PremiumMay 17, 2024Expiry Date0.47Intrinsic Value100Multiplier8DDays to Expiry0.38Time Value100Contract SizeAmericanOptions Type-0.6449Delta0.6340Gamma1.79Leverage Ratio-0.0134Theta-0.0002Rho-1.15Eff Leverage0.0006Vega
Intraday
- 5D
- 1D
News
Novo Nordisk, Flagship to Develop Next-generation Obesity Drugs
Seres Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 412.89% Oppenheimer $5 → $4 Maintains Outperform 05/08/2024 669.33% Chardan Capital $8 → $6 Mai
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersEmbecta (NASDAQ:EMBC) shares increased by 37.7% to $14.14 during Thursday's regular session. The company's market cap stands at $814.1 million. As per the press release, Q2 earnings came out to
Seres Therapeutics Is Maintained at Buy by Chardan Capital
Seres Therapeutics Is Maintained at Buy by Chardan Capital
Express News | Seres Therapeutics : Oppenheimer Cuts Target Price to $4 From $5
Buy Rating Affirmed for Seres Therapeutics Amidst Strong Sales Trajectory and Promising Pipeline
Comments
$Seres Therapeutics(MCRB.US$ Seres Therapeutics Inc - Ser-155 Phase 1B Placebo-Controlled Cohort 2 Clinical Readout Expected End of Q3 2024
1
$Seres Therapeutics(MCRB.US$
their product vowst being referred (theirs is the only fda approved pill type) in the latest released of netflix documentary. no surprise that this has attracted many investors the past couple of days. Perhaps 0.95 - 1 dollar is now the new support. Alot of telling signs pointing to upcoming BO.. people speculating will be by Nestle. If all go smooth, this will be my first investment that gets a BO. 15k shares in it at 0.9 avg. they also have another drug on fda fas...
their product vowst being referred (theirs is the only fda approved pill type) in the latest released of netflix documentary. no surprise that this has attracted many investors the past couple of days. Perhaps 0.95 - 1 dollar is now the new support. Alot of telling signs pointing to upcoming BO.. people speculating will be by Nestle. If all go smooth, this will be my first investment that gets a BO. 15k shares in it at 0.9 avg. they also have another drug on fda fas...
1
Read more